Supha Pharmachem Ltd Q2 Results
- BSE: 539561
- NSE: -
- ISIN: INE549S01036
- Sector: Biotechnology & Drugs
BSE
0.39
0.01 (2.63%)
0.01 (2.63%)Volume2.62 M
Updated: Mon 13 Apr, 2026 | 15:54:18
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹111.06 Cr.(342.79%)
- Operating Profit₹7.37 Cr.(65.67%)
- Profit After Tax₹8.62 Cr.(385.83%)
- Operating Margin6.64%(-62.59%)
Note: Comparison is on YoY basis
Quarterly - Supha Pharmachem Ltd Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 103.69 | 111.50 | -7.00% | 20.63 | 402.54% |
| Depreciation/ Amortization | 0.00 | 0.00 | 200.00% | 0.01 | -96.91% |
| Operating Income | 7.37 | 1.87 | 293.98% | 4.45 | 65.67% |
| Net Income | 8.62 | 4.65 | 85.50% | 1.78 | 385.83% |
| Other Operating Expenses Total | 3.02 | 3.47 | -12.79% | 1.43 | 111.41% |
| Net Income Before Taxes | 10.44 | 5.71 | 82.71% | 2.46 | 324.42% |
| Total Revenue | 111.06 | 113.37 | -2.04% | 25.08 | 342.79% |
| Selling/ General/ Admin Expenses Total | 0.19 | 0.20 | -2.70% | 0.24 | -19.84% |
| Diluted Normalized EPS | 0.10 | 0.05 | 100.00% | 0.03 | 258.17% |